Page 101 - Sohini Das

India's rural mobile phone base slips further, shows Trai report

There are around 931 million active subscribers now (for the top three players) compared to 933 million in June 2018 and 915 million in May 2018.

Airtel Africa London Stock Exchange debut lacklustre, stock falls 15%

Airtel Africa operates across 14 African countries and has over 100 million customers

5G auction: Reliance Jio joins industry chorus for low spectrum pricing

Telcos feel that before fixing spectrum prices, one needs to consider its revenue potential

Broadband India Forum seeks lower reserve prices for 5G spectrum auction

Industry body says Indian reserve prices are 4X international ones; 40% of spectrum on offer last time went unsold due to higher prices

India taps EU to adopt bloc's security recommendations for 5G network

A series of stakeholder meetings are planned among the member states, and the final guidelines are expected by December

Fortis Healthcare turns focus on cost control and consolidation

This is a departure from Fortis' earlier plans that entailed, for example, retail expansion of its diagnostics arm SRL, especially in the southern markets

Telecom industry's revenue growth may improve to double digits in FY21

Analysts project double-digit growth in FY21 to around 12%, largely driven by Jio

Riding on Heinz, Zydus Wellness eyes Rs 4,500-crore turnover in 5 years

Consumer business crucial for Cadila Healthcare, at a time when US and India have pricing pressure

High real interest rates making India uncompetitive, says Ajay Piramal

We will have to think of creative ways to encourage demand like the interest subvention in low-income housing loans, he said

Tower firms' top line woes to continue despite 4G switch: CRISIL report

Telecom operators are pushing consumers to shift to 4G network as it allows them to offer more data services which convert to higher revenue

Fortis Healthcare back in black, reports Rs 135-crore profit in Q4

Fortis has said it is working on balance sheet strengthening through portfolio optimisation and non-core asset monetisation

E-pharmacies find growth pill despite regulatory worries, legal tussles

Top players focus on offline expansion plans

Alembic Pharma forms JV to enter a difficult $100 bn Chinese market

Alembic hold 44% in partnership with China's SPH SINE Pharma, whose stake will be 51%. The JV will set up plant there

Bulk drug exports rise as Indian makers cash in on China's regulatory woes

Iran emerged as a major destination in FY19 with 68% growth after registering negative growth in FY17 and FY18

We have big expectations from Japan and China: Sun Pharma's Dilip Shanghvi

Shangvi feels the domestic market is big enough to accommodate both branded and unbranded medicines

Foreign investors have good appetite for InvITs, says India Inc

Sebi had reduced the minimum subscription limit for InvITs from Rs 10 lakh to Rs 1 lakh last month & raised the leverage limit from 49% to 70%

Political coalition fine, but should work towards progress: India Inc

Adi Godrej felt that the government needed to pay a lot of attention to economic and social development

Dr Reddy's Laboratories renews focus on chronic segment; gets India head

The pharma major is on a restructuring drive

Synergy will bring in Rs 6,200 crore, Vodafone Idea says in capex plan

The capital push comes from a strong need to match rivals on the 4G subscriber base

Local pharma companies to challenge MNCs in pneumonia vaccine space

The Indian market is at present dominated by GlaxoSmithKline Pharma and Pfizer